发明名称 Abuse-Resistant Controlled-Release Opioid Dosage Form
摘要 Abuse-Resistant Controlled-Release Opioid Dosage Form Abuse-resistant, controlled release opioid tablets in combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as an immediate release product as a single dose. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled release matrix and released, over time, with the opioid.
申请公布号 AU2017200011(A1) 申请公布日期 2017.02.02
申请号 AU20170200011 申请日期 2017.01.03
申请人 Mundipharma Pty. Limited 发明人 CARUSO, Frank S.;KAO, Huai-Hung
分类号 A61K9/22;A61K9/20;A61K31/135;A61K31/473;A61K31/485;A61K45/00;A61K47/04;A61K47/12;A61K47/20;A61K47/32;A61K47/38;A61P25/04 主分类号 A61K9/22
代理机构 代理人
主权项
地址